Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Suspended 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Recurrence 1Pancreatic Neoplasms 1Myelodysplastic Syndromes 1Melanoma 1Leukemia, Myeloid, Acute 1Hereditary Sensory and Autonomic Neuropathies 1Brain Neoplasms 1

Interventions

venetoclax 7Azacitidine 5Specimen Handling 4fludarabine phosphate 3Tacrolimus 2Mitoxantrone 2Melphalan 2Cyclophosphamide 2Biopsy 2vactosertib 1regorafenib 1methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside Pt(II) 1iadademstat 1gilteritinib 1fludarabine 1decitabine and cedazuridine drug combination 1beta-apocarotenoid-14',13'-dioxygenase 1ammonium trichloro(dioxoethylene-O,O'-)tellurate 1aldesleukin 1TAK-243 1Stem Cell Transplantation 1Radiotherapy, Intensity-Modulated 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Interleukin-2 1Idarubicin 1IL32 protein, human 1Granulocyte Colony-Stimulating Factor 1Gemtuzumab 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Leukemia, Myeloid, Acute × CA-4948 × Clear all
NCT04278768 2026-03-19

Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Curis, Inc.

Phase 1/2 Suspended
366 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Hereditary Sensory and Autonomic Neuropathies, Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡